Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Cidara Therapeutics, Inc. has filed 798 SEC EDGAR filings since 17 Jun 2014

SEC filing history

Showing 551-575 of 798 matching filings.

Per page
25
Current page
23
4

FORM 4 SUBMISSION

Filing date
01 Feb 2019
Reporting date
31 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Feb 2019
Reporting date
31 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Feb 2019
Reporting date
31 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Feb 2019
Reporting date
31 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Feb 2019
Reporting date
31 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Filing date
28 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Dec 2018
Reporting date
29 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Dec 2018
Reporting date
03 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Dec 2018
Reporting date
03 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Dec 2018
Reporting date
03 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
03 Dec 2018
Reporting date
03 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-228268

424B5

Filing date
16 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-228268

EFFECT filing

Filing date
15 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88806

AMENDMENT NO.2 TO SCHEDULE 13D

Filing date
13 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-228282

FORM S-8

Filing date
08 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36912

CIDARA THERAPEUTICS, INC. FORM 10-Q

Filing date
08 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
08 Nov 2018
Reporting date
08 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
08 Nov 2018
Reporting date
08 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-228268

S-3

Filing date
08 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Sep 2018
Reporting date
14 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Sep 2018
Reporting date
10 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
12 Sep 2018
Reporting date
10 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
12 Sep 2018
Reporting date
12 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

SC 13G/A filing

Filing date
10 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
28 Aug 2018
Reporting date
17 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .